Cybin (HELP) Net Cash Flow (2020 - 2026)
Cybin (HELP) posted quarterly Net Cash Flow of -$37.8 million for Q1 2026, down 4358.43% year-on-year from $887251.5 in Q1 2025, and down 133.91% on a QoQ basis from $111.4 million in Q4 2025.
Cybin (HELP) Net Cash Flow (2020 - 2026) Analysis & Trends
Cybin (HELP) has reported Net Cash Flow for 7 consecutive years, with -$37.8 million the latest figure, recorded in Q1 2026.
- Quarterly Net Cash Flow fell 4358.43% year-over-year to -$37.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $63.6 million (up 205.44% YoY) and the FY2026 annual result came in at $63.6 million, up 206.44% from the prior year.
- Net Cash Flow declined to -$37.8 million in Q1 2026 per HELP's latest filing, from $111.4 million in the prior quarter.
- Over the last five years, Net Cash Flow for HELP reached as high as $126.1 million in Q1 2024 and fell as low as -$37.8 million in Q1 2026.
- A 5-year average of $9.0 million and a median of -$5.4 million in 2023 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2025 — Net Cash Flow soared 663.81% — and 2026, when it sank 4358.43%.
- Year by year, Net Cash Flow stood at -$5.5 million in 2022, then surged by 380.59% to $15.5 million in 2023, then sank by 227.14% to -$19.8 million in 2024, then surged by 663.81% to $111.4 million in 2025, then slumped by 133.91% to -$37.8 million in 2026.
- According to Business Quant data, Net Cash Flow over the past three periods registered -$37.8 million, $111.4 million, and -$34.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 10.56 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 224.46 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 457.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -152.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Cybin | 28.04 Mn | 28.04 Mn | - | -37.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -37.78 Mn |
| Mar 31, 2026 | -37.78 Mn |
| Dec 31, 2025 | 111.42 Mn |
| Dec 31, 2025 | 111.42 Mn |
| Sep 30, 2025 | -34.89 Mn |
| Sep 30, 2025 | -34.89 Mn |
| Jun 30, 2025 | 24.86 Mn |
| Jun 30, 2025 | 24.86 Mn |
| Mar 31, 2025 | -847,450.43 |
| Mar 31, 2025 | -847,450.43 |
| Dec 31, 2024 | -19.76 Mn |
| Dec 31, 2024 | -19.76 Mn |
| Sep 30, 2024 | -19.47 Mn |
| Sep 30, 2024 | -19.47 Mn |
| Jun 30, 2024 | -20.24 Mn |
| Jun 30, 2024 | -20.24 Mn |
| Mar 31, 2024 | 126.11 Mn |
| Mar 31, 2024 | 126.11 Mn |
| Dec 31, 2023 | 15.54 Mn |
| Dec 31, 2023 | 15.54 Mn |